REPL
Replimune Group Inc
Price:  
12.55 
USD
Volume:  
596,389.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

REPL Relative Valuation

-594.2%
Upside

As of 2024-12-14, the Relative Valuation of Replimune Group Inc (REPL) is (62.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.55 USD, the upside of Replimune Group Inc based on Relative Valuation is -594.2%.

The range of the Relative Valuation is (57.37) - (53.22) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 20.7x - 31.0x 25.8x
Forward P/E multiples 18.7x - 19.2x 19.0x
Fair Price (57.37) - (53.22) (62.03)
Upside -557.2% - -524.1% -594.2%
12.55 USD
Stock Price
(62.03) USD
Fair Price

REPL Relative Valuation - Historical P/E Data

Date P/E
2024-11-29 -5.08
2024-11-27 -5.07
2024-11-26 -5.19
2024-11-25 -4.79
2024-11-22 -5.39
2024-11-21 -3.99
2024-11-20 -4.06
2024-11-19 -3.95
2024-11-18 -3.89
2024-11-15 -3.90
2024-11-14 -4.12
2024-11-13 -4.22
2024-11-12 -4.40
2024-11-11 -4.51
2024-11-08 -4.49
2024-11-07 -4.41
2024-11-06 -4.59
2024-11-05 -4.34
2024-11-04 -4.34
2024-11-01 -4.30
2024-10-31 -4.25
2024-10-30 -4.37
2024-10-29 -4.43
2024-10-28 -4.35
2024-10-25 -4.24
2024-10-24 -4.32
2024-10-23 -4.34
2024-10-22 -4.32
2024-10-21 -4.10
2024-10-18 -4.16
2024-10-17 -4.08
2024-10-16 -4.12
2024-10-15 -3.81
2024-10-14 -3.85
2024-10-11 -4.15
2024-10-10 -4.02
2024-10-09 -4.25
2024-10-08 -4.24
2024-10-07 -4.09
2024-10-04 -4.17
2024-10-03 -4.22
2024-10-02 -4.43
2024-10-01 -4.30
2024-09-30 -3.96
2024-09-27 -4.03
2024-09-26 -4.02
2024-09-25 -4.00
2024-09-24 -4.00
2024-09-23 -3.96
2024-09-20 -3.94